PDS Biotechnology Corp
PDSB· Nasdaq
Filed Mar 27, 2020 · 10-K · 87 days after period end · 0001140361-20-007252
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Net Income | -$4.18M | -$1.82M | -$13.91M | -$9.52M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 27, 2020 · 87 d after period end